Home HPTN
Structure		 Research
Sites		 Community Ethics Prevention
Science		 HPTN Studies Network
Information		 Site Map

Study Status Table

 

Studies & Sites Table

 

Studies by Country

 

Studies by Research Area

 

Study Phase Definitions


HPTN 059
Phase II Expanded Safety and Acceptability Study of the Vaginal Microbicide 1% Tenofovir Gel

059 Quick Links

• Study Information

• HPTN 059 Protocol

• HPTN 059 Letters of Amendment

• HPTN 059 Clarification Memos

• HPTN 059 SSP

• HPTN 059 Study Implementation Materials

• HPTN 059 Lab

• HPTN 059 Q & A

• HPTN 059 Meetings & Training

• Other Related Links

• HPTN 059 Alias Lists

Q & A Categories

  • Study Design

  • Eligibility Criteria

  • Administrative, Behavioral, and Regulatory Procedures

  • Clinical Procedures

  • Laboratory Procedures

  • Study Product Considerations

  • Data Collection and Management

  • Human Subjects Considerations

  • Study Monitoring Considerations

  • Other
      
 

Send any questions or comments regarding this site to: hptn@fhi.org
 Please read the HPTN Disclaimer

National Institutes of Health

National Institute of Allergy and Infectious Diseases

This page was last updated: July 18, 2007